An avoidable cause of thymoglobulin anaphylaxis

Por Brabant, S., Facon, A., Provôt, F., Labalette, M., Wallaert, B., Chenivesse, C.
Publicado no Allergy Asthma Clin Immunol (2017)

Eculizumab treatment of atypical haemolytic uraemic syndrome: results from the largest prospective clinical trial to date

Por weekers, LE, Campistol, JM, Espinosa, M, Gaber, AO, Menne, J, Minetti, E, Provot, F, Rondeau, E, Ogawa, M, Bedrosian, CL, hourmant, M
Publicado em 2014

Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction: REFERENECE Study 3-Year Follow Up

Por Frimat, L., Cassuto-Viguier, E., Provôt, F., Rostaing, L., Charpentier, B., Akposso, K., Moal, M. C., Lang, P., Glotz, D., Caillard, S., Ducloux, D., Pouteil-Noble, C., Girardot-Seguin, S., Kessler, M.
Publicado em 2010